In our TWAS, interestingly, predicted expression of APOE in brain substantia nigra and caudate basal ganglia was positively associated with AD risk, and the predicted expression in the pituitary was inversely associated with AD risk. This evidence concerns the gene APOE and Alzheimer disease.